fluoxetine has been researched along with oxytocin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.82) | 18.7374 |
| 1990's | 11 (32.35) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 5 (14.71) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pavel, S | 1 |
| Gibbs, DM | 1 |
| Moos, F; Richard, P | 1 |
| Gard, PR; Mandy, A; Meakin, AJ; Nickels, DP; Whiting, JM | 1 |
| Brownfield, MS; Levy, AD; Li, Q; Rittenhouse, PA; Van de Kar, LD | 1 |
| Battaglia, G; Brownfield, MS; Cabrera, TM; Levy, AD; Li, Q; Van de Kar, LD | 2 |
| Ahmed, I; Aravich, PF; Lauterio, TJ; Rieg, TS | 2 |
| Li, Q; Muma, NA; van de Kar, LD | 1 |
| Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD | 1 |
| Amico, JA; Marar, IE | 1 |
| Battaglia, G; Garcia, F; Muma, NA; Raap, DK; van de Kar, LD; Wolf, WA | 1 |
| Binik, YM; Cantor, JM; Pfaus, JG | 1 |
| Battaglia, G; Garcia, F; Ma, Q; Raap, DK; Serres, F; Van de Kar, LD; Zhang, Y | 1 |
| Battaglia, G; Garcia, F; Muma, NA; Raap, DK; Serres, F; Van de Kar, LD | 1 |
| Battaglia, G; D'Souza, DN; Garcia, F; Van De Kar, LD; Zhang, Y | 2 |
| Jørgensen, H; Kjaer, A; Knigge, U; Møller, M; Warberg, J | 1 |
| Battaglia, G; D'Souza, DN; Damjanoska, KJ; Garcia, F; Kindel, GH; Muma, NA; Van de Kar, LD; Zhang, Y | 1 |
| Elliott, DL; Greenhill, KW; Hofler, VE; Johns, JM; Joyner, PW; Knupp, K; Lomas, LM; McMurray, MS; Middleton, CL; Walker, CH | 1 |
| Battaglia, G; Chen, Z; Frasier, M; Garcia, F; Landry, M; Van De Kar, LD; Zhang, Y | 1 |
| Lolait, SJ; O'Carroll, AM; Roper, JA; Stewart, LQ; Young, WS | 1 |
| Beyer, CE; Dwyer, JM; Leonard, SK; Logue, SF; Malberg, JE; Neal, SJ; Platt, B; Ring, RH; Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Anisman, H; Cossins, AR; Crump, K; Martyniuk, CJ; Mennigen, JA; Popesku, J; Trudeau, VL; Xia, X; Xiong, H; Zhao, E | 1 |
| Chang, JP; Duarte-Guterman, P; Lado, WE; Langlois, VS; Mennigen, JA; Metcalfe, CD; Moon, TW; Trudeau, VL; Zamora, JM | 1 |
| Li, Q; McAllister, CE; Muma, NA; Sullivan, NR; Van de Kar, LD | 1 |
| Li, C; Li, Y; Meng, X; Shen, F; Wang, X | 1 |
| Bashiri, H; Homberg, JR; Houwing, DJ; Salari, AA | 1 |
| Duarte-Guterman, P; Eid, RS; Galea, LAM; Go, KA; Qiu, W; Wen, Y | 1 |
| Amani, M; Homberg, JR; Houwing, DJ; Salari, AA | 1 |
| Anagnostou, E; Baribeau, D; Vorstman, J | 1 |
2 review(s) available for fluoxetine and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Novel treatments in autism spectrum disorder.
Topics: Autism Spectrum Disorder; Cannabinoids; Communication; Fluoxetine; Humans; Multicenter Studies as Topic; Oxytocin; Randomized Controlled Trials as Topic; Transcranial Magnetic Stimulation | 2022 |
32 other study(ies) available for fluoxetine and oxytocin
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The mechanism of action of vasotocin in the mammalian brain.
Topics: Animals; Cats; Fluoxetine; Humans; Hypothalamus; Injections, Intraventricular; Luteinizing Hormone; Male; Melatonin; Neurons; Oxytocin; Pineal Gland; Prolactin; Rats; Serotonin; Sleep; Time Factors; Vasopressins; Vasotocin | 1979 |
Measurement of hypothalamic corticotropin-releasing factors in hypophyseal portal blood.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Fluoxetine; Hypothalamus; Male; Oxytocin; Pituitary Gland; Rats; Serotonin | 1985 |
Serotonergic control of oxytocin release during suckling in the rat: opposite effects in conscious and anesthetized rats.
Topics: Anesthesia; Animals; Animals, Suckling; Cyproheptadine; Female; Fenclonine; Fluoxetine; Lactation; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reflex; Serotonin | 1983 |
Reduction of responses to angiotensin II by antidepressant drugs.
Topics: Acetylcholine; Analysis of Variance; Angiotensin II; Animals; Antidepressive Agents; Binding, Competitive; Cocaine; Desipramine; Drinking; Drug Interactions; Female; Fluoxetine; In Vitro Techniques; Isoproterenol; Male; Oxytocin; Rats; Rats, Wistar; Tranylcypromine; Uterine Contraction; Uterus | 1994 |
Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion.
Topics: Animals; Fenfluramine; Fluoxetine; Ibotenic Acid; Male; Neurons; Oxytocin; p-Chloroamphetamine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Serotonin; Supraoptic Nucleus | 1995 |
Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Brain; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hormones; Male; Oxytocin; Prolactin; Pyrimidines; Rats; Rats, Wistar; Receptors, Serotonin; Renin; Vasopressins | 1994 |
Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: relationship to anorexia nervosa.
Topics: Animals; Anorexia Nervosa; Behavior, Animal; Body Weight; Dynorphins; Eating; Fluoxetine; Male; Oxytocin; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Suprachiasmatic Nucleus; Supraoptic Nucleus; Vagus Nerve; Vasopressins | 1993 |
Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Cerebral Cortex; Desipramine; Fluoxetine; Hypothalamus; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin | 1993 |
Fluoxetine induces thymus oxytocin abnormalities in activity-based anorexia.
Topics: Animals; Anorexia; Fluoxetine; Male; Oxytocin; Physical Exertion; Rats; Rats, Sprague-Dawley; Thymus Gland | 1993 |
Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; GTP-Binding Proteins; Hypothalamus; Male; Mesencephalon; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1996 |
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1996 |
Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat.
Topics: Animals; Corticotropin-Releasing Hormone; Drinking; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sodium; Supraoptic Nucleus; Vasopressins | 1998 |
Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Brain; Drug Interactions; Fluoxetine; GTP-Binding Protein alpha Subunits, Gi-Go; Hypothalamus; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 1999 |
Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin.
Topics: Animals; Body Weight; Ejaculation; Fluoxetine; Male; Oxytocin; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Sexual Behavior, Animal | 1999 |
Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Behavior, Animal; Body Weight; Conditioning, Psychological; Corticosterone; Defecation; Fluoxetine; Male; Neurosecretory Systems; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Renin; Selective Serotonin Reuptake Inhibitors; Stress, Physiological | 2000 |
Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Fluoxetine; GTP-Binding Protein alpha Subunits, Gi-Go; Hypothalamus; Male; Oxytocin; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists | 2000 |
Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Body Weight; Cerebral Cortex; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Hypothalamus; Injections, Intraventricular; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides.
Topics: Animals; Corticotropin-Releasing Hormone; Fluoxetine; Gene Expression Regulation; Male; Oxytocin; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Serotonin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Supraoptic Nucleus; Vasopressins | 2003 |
Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
Topics: Animals; Body Weight; Corticotropin-Releasing Hormone; Fluoxetine; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Indophenol; Male; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RGS Proteins; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Time Factors; Type C Phospholipases | 2003 |
Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Body Weight; Brain; Corticosterone; Diet; Fluoxetine; Hormones; Male; Neurosecretory Systems; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Tryptophan | 2004 |
The effects of dopaminergic/serotonergic reuptake inhibition on maternal behavior, maternal aggression, and oxytocin in the rat.
Topics: Aggression; Animals; Behavior, Animal; Brain; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluoxetine; Male; Maternal Behavior; Nalidixic Acid; Naphthyridines; Oxytocin; Postpartum Period; Pregnancy; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2005 |
Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin.
Topics: Adrenocorticotropic Hormone; Aging; Animals; Body Weight; Brain; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Neurosecretory Systems; Oxytocin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Renin; Reproduction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 2005 |
The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Desipramine; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Knockout; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Receptors, Vasopressin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2008 |
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal; Body Temperature Regulation; Calcium; Cell Line; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fear; Fluoxetine; Humans; In Vitro Techniques; Male; Maze Learning; Mice; Motor Activity; Neuropeptides; Oxytocin; Peptide Fragments; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2008 |
Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus).
Topics: Animals; Chromatography, High Pressure Liquid; Dopamine; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fluoxetine; Gene Expression; Goldfish; Hypothalamus; Injections, Intraperitoneal; Neurosecretory Systems; Norepinephrine; Oligonucleotide Array Sequence Analysis; Oxytocin; Radioimmunoassay; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Serotonin; Telencephalon | 2008 |
Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus.
Topics: Animals; Aromatase; Base Sequence; Estrogen Receptor alpha; Fish Proteins; Fluoxetine; Gene Expression; Goldfish; Liver; Male; Molecular Sequence Data; Oxytocin; Prostaglandins F; Reproduction; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Testis; Testosterone; Water Pollutants, Chemical | 2010 |
Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Drug Interactions; Estradiol; Female; Fluoxetine; Hippocampus; Oxytocin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Signal Transduction | 2013 |
Depression-like behaviors in tree shrews and comparison of the effects of treatment with fluoxetine and carbetocin.
Topics: Anhedonia; Animals; Antidepressive Agents; Depression; Electroshock; Fluoxetine; Helplessness, Learned; Male; Oxytocin; Social Behavior; Stress, Psychological; Tupaiidae | 2016 |
The combination of fluoxetine and environmental enrichment reduces postpartum stress-related behaviors through the oxytocinergic system and HPA axis in mice.
Topics: Animals; Anxiety; Anxiety Disorders; Brain; Depression, Postpartum; Disease Models, Animal; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Maternal Behavior; Mice; Oxytocin; Pituitary-Adrenal System; Postpartum Period; Pregnancy; Receptors, Oxytocin; Stress, Psychological | 2021 |
Maternal fluoxetine reduces hippocampal inflammation and neurogenesis in adult offspring with sex-specific effects of periadolescent oxytocin.
Topics: Adult Children; Animals; Autism Spectrum Disorder; Doublecortin Protein; Female; Fluoxetine; Hippocampus; Humans; Inflammation; Male; Neurogenesis; Oxytocin; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2021 |
Perinatal fluoxetine dose-dependently affects prenatal stress-induced neurobehavioural abnormalities, HPA-axis functioning and underlying brain alterations in rat dams and their offspring.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain; Female; Fluoxetine; Hippocampus; Lactation; Male; Maternal Behavior; Oxytocin; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2021 |